Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
10/2003
10/23/2003US20030198982 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
10/23/2003CA2481572A1 Method for synthesizing .beta.-l-5-fluoro-2',3'-dideoxy-2',3'-didehydrocytidine(.beta.-l-fd4c)
10/23/2003CA2480359A1 Process for manufacturing purified phosphorodiamidite
10/22/2003EP1354064A2 Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
10/22/2003EP1281715B1 Process for the preparation of ribavirin
10/22/2003EP1194441B1 A2a receptor agonists
10/21/2003US6635753 Process for the preparation of substantially pure stavudine and related intermediates useful in the preparation thereof
10/21/2003CA2154999C Deoxygenation of cis vicinal diols
10/16/2003WO2003084975A1 New analogs of nitrobenzylthioinosine
10/16/2003WO2003048387A3 Labelled nucleotides
10/16/2003WO2003027314A3 Protected linker compounds
10/16/2003WO2002059084A3 Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof
10/16/2003US20030195332 PNA monomer and precursor
10/16/2003US20030194741 Three blocking groups are independently removable under 3 different conditions; using new protection schemes and solid phase synthesis, oligonucleotides are obtained in 5' to 3' direction using phosphoamidites and avoiding depurination
10/16/2003US20030194740 System and method for nucleic acid sequencing by polymerase synthesis
10/16/2003US20030194722 Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety
10/15/2003EP1352910A1 New analogs of nitrobenzylthioinosine
10/15/2003EP1351966A1 Improved specificity in treatment of diseases
10/15/2003EP0877751B1 Linker arm for solid support oligonucleotide synthesis and process for production thereof
10/14/2003CA2114838C A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
10/09/2003WO2003082890A1 Diastereoselective process for preparing of beta-d and beta-l 2' , 3' -dideoxy nucleoside analogs
10/09/2003WO2003052132A3 Linear and hairpin oligonucleotide analogues comprising intercalator pseudonucleotides
10/09/2003WO2002078747A3 Pregabalin lactose conjugates
10/09/2003US20030191303 Labelled oligonucleotides synthesized on solid-supports
10/09/2003US20030191127 Process for preparing substituted benzimidazole compounds
10/09/2003US20030190680 Photocleavable bioreactive agents
10/08/2003EP1141137B1 Water-soluble rhodamine dyes and conjugates thereof
10/08/2003EP1070068B1 Granulatimide derivatives for use in cancer treatment
10/08/2003EP1068346B1 Nucleotide activated disaccharides and oligosaccharides and method for the production thereof
10/08/2003EP1068345B1 Nucleotide activated disaccharides and oligosaccharides and a method for the production thereof
10/08/2003CN1447692A Methods of drug delivergy to hepatocytes and treatment of flaviviridae infections
10/07/2003US6630581 Condensing the 3'-OH or 5'-OH group of a support-bound nucleoside or oligonucleotide with a monomeric nucleoside phosphoramidite having a carbonate-protected hydroxyl group; treating the intermediate provided with a deprotecting reagent
10/07/2003US6630579 Complex
10/07/2003US6630308 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
10/07/2003CA2100027C Method of producing 5'-nucleotide
10/02/2003WO2003080649A2 Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors
10/02/2003WO2003080620A1 Inhibitors of nucleoside phosphorylases and nucleosidases
10/02/2003WO2003052133A3 Oligonucleotide analogues comprising intercalator pseudonucleotides
10/02/2003WO2002018404A9 Nucleoside derivatives for the treatment of hepatitis c
10/02/2003US20030187240 Nuclease resistant
10/02/2003US20030187237 Determining nucleotide sequences via sequential removal of nucleotides from one end of at least one nucleic acid, transporting through a channel and identifying nucleotide by raman spectroscopy
10/02/2003US20030186930 Uridine analogs and techniques for making and using
10/02/2003US20030186929 Inotropic agents; for increasing cardiac muscle contractility, diastolic relaxation, and increasing vasodilation
10/02/2003US20030186928 Method for reducing intraocular pressure
10/02/2003US20030186926 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
10/02/2003US20030186924 Prodrugs
10/02/2003US20030186917 Method of treating edematous retinal disorders
10/02/2003US20030186296 Microarray comprised of polynucleotide or polypeptide biopolymer substrate for use in cancer diagnosis
10/02/2003US20030186255 Multichannel microfluidic system for sequencing preferential nucleotide sequences
10/02/2003US20030186231 Systematic evolution of ligands by exponential enrichment: Chemi-ESLEX
10/01/2003EP1348712A1 L-nucleic acid derivatives and processes for the synthesis thereof
10/01/2003EP1348466A2 Method for treating pain with adenosine-tetraphosphates
10/01/2003EP1348035A2 Method for base sequencing and biologically active nucleic acids
10/01/2003EP1155027B1 Synthesis of labelled oligonucleotides on solid-supports
10/01/2003CN1446225A 5'-deoxy-N-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
10/01/2003CN1445012A Method for solid-liquid separation of ferment fluid in carnine production
10/01/2003CN1122671C Arbinosyl furanuridine compound and its synthetising process
09/2003
09/30/2003US6627400 Contacting a binding compound having reporters molecules with a sample; cleaving; electrophoretically separating and identifying the released reporter molecules
09/30/2003US6627215 Devices for improved wound management
09/25/2003WO2003078447A1 Benzodeazaadenine derivative base and electronic material containing the same
09/25/2003WO2003061568A3 Methods and therapeutic compositions in the treatment of advanced cancer
09/25/2003US20030181713 Processes for the synthesis of chloroadenosine and methylthioadenosine
09/25/2003US20030180757 Nucleic acid labeling compounds
09/24/2003EP1346724A1 Remedies for hepatitis c
09/24/2003EP1181302B1 Orally active a1 adenosine receptor agonists
09/24/2003EP1177202B1 4'-c-ethynyl purine nucleosides
09/24/2003EP1177201B1 4'-c-ethynyl pyrimidine nucleosides
09/24/2003EP0938322B1 Use of uridine triphosphate related compounds for the prevention and treatment of pneumonia in immobilized patients
09/24/2003CN1444483A Methods for treating hepatitis delta virus infection with beta-L-2' deoxy-uncleosides
09/24/2003CN1122040C Suger modified nucleosides and their use of synthesis of oligonucleotide
09/23/2003US6624294 Dissolving nucleoside in solvent to form a solution; cooling; treating with base; warming; reacting with ester to effect alkylation of 2' position of a 2',3'-dihydroxy sugar moiety of a nucleoside
09/23/2003US6624158 Purine derivatives
09/18/2003WO2003077215A2 Fluorescent nitrogenous base and nucleosides incorporating same
09/18/2003WO2003062445A3 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis
09/18/2003US20030176680 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
09/18/2003US20030176677 Pyrimidine derivatives for labeled binding partners
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection
09/18/2003US20030176392 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV")
09/18/2003US20030176390 Methods of treating insulin resistance syndrome and diabetes
09/18/2003US20030176370 Anti-viral pyrimidine nucleoside analogues
09/18/2003US20030176319 N4-acylcytosine-1,3- dioxolane nucleosides for treatment of viral infections
09/18/2003US20030175751 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis
09/18/2003US20030175747 Microfluidic apparatus for detection, separation and classification multiple DNA sequences; restriction fragment length polymorphisms
09/18/2003US20030175728 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for PCR analysis
09/17/2003EP1147119B1 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
09/17/2003EP1027359B9 Monocyclic l-nucleosides, analogs and uses thereof
09/17/2003EP0941099B1 Treatment of bronchitis with diuridine tetraphosphate
09/17/2003EP0909184B1 Targeted drug delivery using sulfonamide derivatives
09/17/2003EP0724647A4 Nucleic acid ligands and improved methods for producing the same
09/17/2003EP0702683B1 06-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells
09/17/2003CN1443191A Methods and compositions for treating hepatitis c virus
09/17/2003CN1443189A Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
09/17/2003CN1442420A Method of preparing 2'-deoxy-2',2'-difluoro-beta-nucleoside or its medical salt using 1,6-dehydro-beta-D-glucose as raw material
09/17/2003CN1121441C Method of detecting lung disease
09/16/2003US6620926 Composition for use in the generation and purification of oligonucleotide sequences
09/16/2003US6620921 1,2,3,5,6-penta-O-propanoyl-beta-D-glucofuranose in crystalline form; prepared by reacting D-glucose, boric acid and propanoic anhydride; useful for preparation of glycosides
09/16/2003US6620796 Combinatorial library synthesis and pharmaceutically active compounds produced thereby
09/16/2003US6620596 Reacting glyoxal-guanine with ribose-1-phosphate or 2-deoxyribose-1-phosphate in the presence of purine nucleoside phosphorylase; decomposition with an alkali to produce guanosine or 2*-deoxyguanosine; efficiency
09/16/2003CA2238736C Novel a1 adenosine receptor agonists and antagonists
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 201